Wegovy pill expands weight loss options in the USJanuary 8, 2026 MENA Newswire, NEW YORK: Novo Nordisk’s blockbuster weight-loss drug Wegovy is now available in an oral pill form in the United States, marking a major…
Uninsured U.S. patients get Ozempic for $499 per monthAugust 18, 2025 Uninsured Americans can now access Ozempic for $499 monthly as Novo Nordisk rolls out a direct-to-consumer model through telehealth providers.
Novo Nordisk stock plunges as sales forecast slashed and new CEO namedJuly 29, 2025 Novo Nordisk shares dropped 20% after cutting full-year guidance and naming a new CEO, citing U.S. market weakness for Wegovy and Ozempic.